Conatus' Failure Was A Blow, But The Most Important Study Is Yet To Come [Seeking Alpha]
CONATUS PHARMACEUTICALS INC (CNAT)
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.conatuspharma.com/investor-relations
Company Research
Source: Seeking Alpha
Recently, Conatus Pharmaceuticals ( CNAT ) reported results from a phase 2b study known as ENCORE-PH. It noted that this study had failed to meet on the primary endpoint; however, there are still many shots on goal left. This is why I believe that this biotech has a chance to recover. For starters, final data from the ENCORE-PH study is going to be reported by mid-2019. In addition, the 1st half of 2019 has two other studies that are set to report results which are ENCORE-NF and ENCORE-LF. Phase 2 ENCORE-PH The phase 2b study that didn't perform as well is known as ENCORE-PH and it recruited a total of 263 patients with compensated or early decompensated liver cirrhosis and severe portal hypertension. The final outcome of the study was that the primary endpoint was not met. The primary endpoint was looking to see if emricasan could reduce portal hypertension in a statistically significant manner over placebo. It didn't achieve this primary endpoint; however, there were s
Show less
Read more
Impact Snapshot
Event Time:
CNAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CNAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CNAT alerts
High impacting CONATUS PHARMACEUTICALS INC news events
Weekly update
A roundup of the hottest topics